CASPR2-B

Bo Sun1,2, Dominique Fernandes3,4, John Soltys1,5

  • 1Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, Oxford, UK.

Science advances
|April 16, 2025
PubMed
概括

研究人员在健康个人和患者中确定了对接触因相关蛋白类2 (CASPR2) 有反应性的未变异B细胞. 针对CASPR2的致病性,突变的记忆B细胞仅限于患者,揭示了CASPR2自身抗体脑炎的免疫耐受性缺陷.